Lonsurf Dosing Calculator Guide: BSA-Based Trifluridine/Tipiracil Dosing, Tablet Planning, and Practical Cycle Management
A Lonsurf dosing calculator helps clinicians and care teams quickly estimate an individualized dose based on body surface area (BSA), then convert that dose into practical tablet counts for real-world administration. Lonsurf, the oral combination of trifluridine and tipiracil, is generally dosed using a BSA-based formula and a repeating 28-day treatment cycle. Because the dose is given twice daily only on selected days, both dose math and schedule planning are important to reduce medication errors and support adherence.
This page is designed to support dose estimation workflow: calculate BSA, compute the standard mg/m²-based dose, round to practical increments, apply the per-dose ceiling, and translate the result into tablet combinations. It also summarizes timing across the cycle and highlights key safety points that should always be verified against the latest product labeling and institutional protocols.
What this Lonsurf dosing calculator does
The calculator follows a common workflow used in oncology clinics:
- Uses either auto-calculated BSA (Mosteller method) or manually entered BSA.
- Applies the standard dose formula of 35 mg/m² per dose.
- Rounds to 5 mg increments for practical tablet use.
- Caps the dose at 80 mg per dose.
- Shows twice-daily total and complete-cycle total for treatment days.
- Suggests a tablet mix using 15 mg and 20 mg tablet strengths to match the target dose.
How BSA is calculated
When height and weight are available, this page uses the Mosteller equation:
BSA (m²) = sqrt( height(cm) × weight(kg) / 3600 )
This formula is widely used in oncology because it is simple, fast, and clinically familiar. If a verified BSA already exists in the chart for the same treatment date, manual entry can be used directly to avoid rounding drift from repeated recalculation.
Lonsurf dosing structure in a 28-day cycle
Lonsurf is not taken every day continuously. The standard pattern is:
- Twice daily on Days 1 through 5
- No dosing on Days 6 and 7
- Twice daily again on Days 8 through 12
- No dosing on Days 13 through 28
This means there are 10 treatment days per cycle and 20 total doses per cycle. Understanding this structure is essential for accurate dispensing, refill planning, and patient counseling. The calculator therefore reports not only per-dose and per-day values, but also a cycle total in milligrams to support pharmacy and scheduling workflows.
Tablet strengths and dose matching
Lonsurf dose implementation typically uses combinations of 15 mg and 20 mg tablets. Because the target per-dose amount is rounded to 5 mg increments, tablet matching can be performed reliably for standard adult dose points. The calculator returns a practical combination with minimal tablet burden when an exact match is available.
When dispensing, teams commonly double-check three points: total milligrams per dose, number of tablets per dose, and number of dosing days in the cycle segment. This three-step check reduces common oral oncolytic errors such as accidental daily dosing throughout the full month or carrying over a previous cycle dose after a toxicity event.
Why accurate Lonsurf dose math matters
Small arithmetic differences can produce large treatment differences over an entire cycle. An error of 5 mg per dose can translate into 100 mg difference across 20 doses in one cycle. In oral oncology, dose confusion can occur during transitions between clinic, pharmacy, and home administration. A clear calculator output improves communication between prescriber, pharmacist, infusion center or specialty clinic, and patient/caregiver.
Accurate dosing is especially important when treatment is being adjusted for tolerability. If dose changes are required between cycles, all cycle instructions should be rewritten clearly with the updated per-dose milligrams and revised tablet counts, rather than relying on prior written directions.
Clinical context and monitoring considerations
Lonsurf treatment decisions are made in the context of overall disease status, prior therapy, performance status, blood counts, and patient-specific risk factors. As with many antineoplastic regimens, hematologic monitoring is central to safe use. Baseline and interval labs, timing of cycle start, and treatment holds should follow current labeling and local protocol requirements.
In routine practice, oncology teams often use a structured pre-cycle checklist that includes CBC review, symptom/toxicity assessment, confirmation of dose level, and medication reconciliation. This is particularly useful for oral regimens where administration occurs at home and adverse events may emerge between visits.
Patient counseling points that improve adherence
Even with correct prescribing, outcomes can be affected by missed doses, schedule confusion, or incorrect tablet use. Practical counseling points include:
- Use a calendar that specifically marks Days 1–5 and 8–12 as treatment days.
- Take doses after morning and evening meals according to clinical instructions.
- Do not “make up” missed doses unless advised by the oncology team.
- Store tablets safely and keep a written daily dose checklist.
- Report fever, unusual fatigue, bleeding signs, or severe gastrointestinal symptoms promptly.
When possible, provide both milligram dose and exact tablet count in plain language. For example: “Take total 55 mg in the morning and 55 mg in the evening on treatment days,” followed by the exact tablet composition. This reduces ambiguity compared with tablet-only instructions.
How clinics can use this calculator in workflow
For clinical teams, a practical process is:
- Enter same-day weight and height or validated BSA.
- Generate per-dose amount and tablet mix.
- Verify dose level against current treatment plan and recent labs.
- Print or transcribe a cycle-specific administration calendar.
- Document the final prescribed dose and rationale for any adjustments.
This approach creates a repeatable, auditable process that aligns prescribing with dispensing and home administration. It also supports continuity when coverage providers or cross-site teams are involved in patient care.
Frequently asked questions about Lonsurf dosing
Is Lonsurf dosed by body weight alone?
No. Standard dosing is BSA-based, not weight-only.
How often is Lonsurf taken during treatment weeks?
Twice daily on scheduled treatment days in the 28-day cycle pattern.
Can this calculator replace prescribing information?
No. It is a calculation aid. Final prescribing decisions must follow current official labeling, institutional policy, and oncologist judgment.
Why is an 80 mg cap shown?
Per-dose ceiling logic is built in to reflect standard dosing limits used in clinical references.
Important medical disclaimer
This calculator and article are educational tools for dose estimation support. They do not provide diagnosis, treatment recommendations, or individualized medical advice. Lonsurf prescribing requires qualified oncology supervision, review of current product labeling, and patient-specific clinical assessment. Always verify calculations, lab criteria, contraindications, interactions, and dose modifications before use.